Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.1%

25 terminated/withdrawn out of 89 trials

Success Rate

57.6%

-28.9% vs industry average

Late-Stage Pipeline

10%

9 trials in Phase 3/4

Results Transparency

76%

26 of 34 completed trials have results

Key Signals

21 recruiting26 with results17 terminated8 withdrawn

Enrollment Performance

Analytics

N/A

37(54.4%)

Phase 2

14(20.6%)

Phase 4

8(11.8%)

Phase 1

6(8.8%)

Early Phase 1

2(2.9%)

Phase 3

1(1.5%)

68Total

N/A(37)

Phase 2(14)

Phase 4(8)

Phase 1(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (89)

Showing 20 of 89 trials

NCT05422690Phase 2Recruiting

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Role: lead

NCT05433220Not ApplicableRecruiting

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova

Role: lead

NCT07485322Not ApplicableRecruiting

Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center

Role: lead

NCT05710315Not ApplicableActive Not Recruiting

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

Role: lead

NCT06931561Not ApplicableRecruiting

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

Role: lead

NCT06273891Phase 3Active Not Recruiting

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes

Role: lead

NCT05652218Not ApplicableActive Not Recruiting

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Role: lead

NCT05977686Recruiting

Hemoglobin Testing in Pregnant Patients

Role: lead

NCT06939751Recruiting

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

Role: lead

NCT07437339Phase 4Recruiting

Volume Reduction for Open Fracture Irrigation

Role: lead

NCT07167199Not ApplicableNot Yet Recruiting

Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery

Role: lead

NCT05370820Phase 2Recruiting

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Role: lead

NCT04282850Not ApplicableTerminated

Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

Role: lead

NCT06532890Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Role: lead

NCT04419480Not ApplicableRecruiting

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Role: lead

NCT03378739Recruiting

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Role: lead

NCT06273683Recruiting

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

Role: lead

NCT06746428Not ApplicableRecruiting

Activity Coaching During Pelvic Radiation Therapy

Role: lead

NCT06501989Phase 2Withdrawn

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Role: lead

NCT05338060Completed

A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer

Role: lead